Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Divi’s Laboratories has informed that it enclosed the schedule of earnings conference call for the 4th quarter and year ended March 31, 2024 to be held on May 25, 2024 at 14:30 hrs (IST).
The above information is a part of company’s filings submitted to BSE.